Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Left ventricular myocardial work improves in response to treatment and is associated with survival among patients with light chain cardiac amyloidosis.
Briasoulis A, Bampatsias D, Petropoulos I, Rempakos A, Patras R, Theodorakakou F, Makris N, Dimopoulos MA, Stamatelopoulos K, Kastritis E. Briasoulis A, et al. Among authors: stamatelopoulos k. Eur Heart J Cardiovasc Imaging. 2024 Apr 30;25(5):698-707. doi: 10.1093/ehjci/jead351. Eur Heart J Cardiovasc Imaging. 2024. PMID: 38142437
Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart disease.
Stamatelopoulos K, Sibbing D, Rallidis LS, Georgiopoulos G, Stakos D, Braun S, Gatsiou A, Sopova K, Kotakos C, Varounis C, Tellis CC, Kastritis E, Alevizaki M, Tselepis AD, Alexopoulos P, Laske C, Keller T, Kastrati A, Dimmeler S, Zeiher AM, Stellos K. Stamatelopoulos K, et al. J Am Coll Cardiol. 2015 Mar 10;65(9):904-16. doi: 10.1016/j.jacc.2014.12.035. J Am Coll Cardiol. 2015. PMID: 25744007 Free article.
Clinical and prognostic significance of serum levels of von Willebrand factor and ADAMTS-13 antigens in AL amyloidosis.
Kastritis E, Papassotiriou I, Terpos E, Roussou M, Gavriatopoulou M, Komitopoulou A, Skevaki C, Eleutherakis-Papaiakovou E, Pamboucas C, Psimenou E, Manios E, Giannouli S, Politou M, Gakiopoulou H, Papadopoulou E, Stamatelopoulos K, Tasidou A, Dimopoulos MA. Kastritis E, et al. Among authors: stamatelopoulos k. Blood. 2016 Jul 21;128(3):405-9. doi: 10.1182/blood-2016-02-702696. Epub 2016 May 10. Blood. 2016. PMID: 27166361 Free article. Clinical Trial.
Evidence of a Redox-Dependent Regulation of Immune Responses to Exercise-Induced Inflammation.
Sakelliou A, Fatouros IG, Athanailidis I, Tsoukas D, Chatzinikolaou A, Draganidis D, Jamurtas AZ, Liacos C, Papassotiriou I, Mandalidis D, Stamatelopoulos K, Dimopoulos MA, Mitrakou A. Sakelliou A, et al. Among authors: stamatelopoulos k. Oxid Med Cell Longev. 2016;2016:2840643. doi: 10.1155/2016/2840643. Epub 2016 Nov 15. Oxid Med Cell Longev. 2016. PMID: 27974950 Free PMC article.
Cardiac and renal complications of carfilzomib in patients with multiple myeloma.
Dimopoulos MA, Roussou M, Gavriatopoulou M, Psimenou E, Ziogas D, Eleutherakis-Papaiakovou E, Fotiou D, Migkou M, Kanellias N, Panagiotidis I, Ntalianis A, Papadopoulou E, Stamatelopoulos K, Manios E, Pamboukas C, Kontogiannis S, Terpos E, Kastritis E. Dimopoulos MA, et al. Among authors: stamatelopoulos k. Blood Adv. 2017 Feb 27;1(7):449-454. doi: 10.1182/bloodadvances.2016003269. eCollection 2017 Feb 28. Blood Adv. 2017. PMID: 29296960 Free PMC article.
Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study.
Fotiou D, Sergentanis TN, Papageorgiou L, Stamatelopoulos K, Gavriatopoulou M, Kastritis E, Psaltopoulou T, Salta S, Van Dreden P, Sangare R, Larsen AK, Terpos E, Elalamy I, Dimopoulos MA, Gerotziafas GT. Fotiou D, et al. Among authors: stamatelopoulos k. Blood Cancer J. 2018 Nov 7;8(11):102. doi: 10.1038/s41408-018-0135-y. Blood Cancer J. 2018. PMID: 30405097 Free PMC article.
Pegylated interferon and ribavirin treatment for chronic hepatitis C deteriorates subclinical markers of vascular function.
Georgiopoulos G, Alexopoulou A, Pouriki S, Vasilieva L, Laina A, Bampatsias D, Mani I, Kontogiannis C, Tousoulis D, Stamatelopoulos K, Dourakis SP. Georgiopoulos G, et al. Among authors: stamatelopoulos k. Hellenic J Cardiol. 2019 Mar-Apr;60(2):143-145. doi: 10.1016/j.hjc.2018.07.001. Epub 2018 Jul 6. Hellenic J Cardiol. 2019. PMID: 31146885 Free article. No abstract available.
264 results